2The American Fertility Society. Revised American Fertility Society classification of endometriosis : 1985. Fertil Steril, 1985,43 : 351- 352.
3Seibert V, Ebert MP, Buschmann T. Advances in clinical cancer proteomics : SELDI-TOF-mass spectrometry and biomarker discovery. Brief Funct Genomic Proteomic ,2005,4 : 16-26.
4Abrao MS, Podgaec S, Filho BM, et al. The use of biochemical markers in the diagnosis of pelvic endometriosis. Hum Reprod, 1997,12:2523-2527.
5Bedaiwy MA, Falcone T. Laboratory testing for endometriosis. Clin Chim Acta, 2004,340:41-56.
6Telimaa S, Kauppila A, Ronnberg L, et al. Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis. Suppression by treatment with danazol and high- dose medroxyprogesterone acetate. Am J Obstet Gynecol, 1989, 161:866-871.
7Gupta S, Agarwal A, Sekhon L, et al. Serum and peritoneal abnormalities in endometriosis : potential use as diagnostic markers. Minerva Ginecol,2006,58:527-551.
8Bedaiwy MA, Falcone T, Sharma RK, et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod, 2002,17:426-431.
9Abrao MS, Podgaec S, Pinotti JA, et al. Tumor markers in endometriosis. Int J Gynaecol Obstet,1999,66 : 19-22.
10Somigliana E, Vigano P, Tirelli AS, et al. Use of the concomitant serum dosage of CA125, CA199 and interleukin--6 to detect the presence of endometriosis-results from a series of reproductive age women undergoing laparoscopic surgery for benign gynecological conditions. Hum Reprod,2004, !9 : 1871-1876.
